Exabis Library:
How Do We Treat Inflammatory Bowel Diseases to Aim For Endoscopic Remission? - Clinical Gastroenterology and Hepatology
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Topical Reviews
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
Ulcerative Colitis (UC): Efficacy | STELARA® (ustekinumab) HCP
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
Proposed terminology for types of remission and their common... | Download Scientific Diagram
ECCO-EFCCA Patient Guidelines on Ulcerative Colitis (UC) Introduction
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease | NEJM Evidence
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease - Fernandes - United European Gastroenterology Journal - Wiley Online Library
Definition of Remission and Relapse | Download Scientific Diagram
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical M
Review article: defining remission in ulcerative colitis - Travis - 2011 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra
Efficacy & Remission Data | SKYRIZI® (risankizumab-rzaa)
PDF) European Crohn's and Colitis Organization (ECCO)
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
PDF) Mesalamine enemas for induction of remission in oral mesalamine refractory pediatric ulcerative colitis: a prospective cohort study | Mona Boaz - Academia.edu
Serum biomarkers confirming stable remission in inflammatory bowel disease | Scientific Reports
ECCO
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial - The Lancet Gastroenterology & Hepatology
Efficacy Results | Ulcerative Colitis | RINVOQ® (upadacitinib)
Frontiers | Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology
IBD GAPPS Infographic_r13
